CXCL2, a new critical factor and therapeutic target for cardiovascular diseases

Area of Science:

• Cardiovascular research
• Immunology
• Molecular biology

Background:

• Cardiovascular diseases (CVDs) are a leading global cause of mortality.
• Inflammatory chemokines are implicated in various physiological processes and increasingly in CVD pathogenesis.
• CXC motif chemokine ligand 2 (CXCL2) is a key inflammatory chemokine potentially involved in cardiovascular disease development.

Purpose of the Study:

• To review the expression changes of CXCL2 in major cardiovascular conditions including acute myocardial infarction (AMI), atherosclerosis (AS), obesity, diabetes, and ischemic stroke (IS).
• To elucidate the potential role of CXCL2 in the pathogenesis of cardiovascular diseases.
• To provide novel insights for the prevention and treatment strategies for CVDs.

Main Methods:

• Literature review of studies investigating CXCL2 expression and function in cardiovascular disease models and human patients.
• Analysis of existing research on the signaling pathways and biological effects of CXCL2 in the cardiovascular system.
• Synthesis of findings related to CXCL2's involvement in AMI, AS, obesity, diabetes, and IS.

Main Results:

• CXCL2 expression is altered in various cardiovascular diseases such as AMI, AS, obesity, diabetes, and IS.
• CXCL2 mediates inflammatory responses within the cardiovascular system.
• The precise signaling pathways of CXCL2 in CVD remain incompletely understood and require further investigation.

Conclusions:

• CXCL2 plays a significant role in the inflammatory processes underlying cardiovascular diseases.
• Understanding CXCL2's function and signaling pathways is crucial for developing targeted therapies.
• Further research into CXCL2 is warranted to explore its therapeutic potential in preventing and treating CVDs.